NOMAD POWER SOLUTIONS, INC. Share-based Payment Arrangement, Expense, after Tax
NOMAD POWER SOLUTIONS, INC. (NMAD) reported Share-based Payment Arrangement, Expense, after Tax of $3.93 thousand for the 3-month period ending 2016-09-30, per its 10-Q filed 2016-11-04.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax · last filed 2016-11-04
- NOMAD POWER SOLUTIONS, INC. share-based payment arrangement, expense, after tax for the quarter ending 2016-09-30 was $3.93K.
- NOMAD POWER SOLUTIONS, INC. share-based payment arrangement, expense, after tax for the quarter ending 2016-06-30 was $101.40K.
- NOMAD POWER SOLUTIONS, INC. share-based payment arrangement, expense, after tax for the quarter ending 2016-03-31 was $0.00, a 100.00% decline year-over-year.
- NOMAD POWER SOLUTIONS, INC. share-based payment arrangement, expense, after tax for the quarter ending 2015-12-31 was $0.00, a 100.00% decline year-over-year.
- NOMAD POWER SOLUTIONS, INC. share-based payment arrangement, expense, after tax for fiscal 2015 was $74.90K, a 90.14% decline from fiscal 2014.
- NOMAD POWER SOLUTIONS, INC. share-based payment arrangement, expense, after tax for fiscal 2014 was $759.60K, a 536.98% increase from fiscal 2013.
- NOMAD POWER SOLUTIONS, INC. share-based payment arrangement, expense, after tax for fiscal 2013 was $119.25K.
| Period end | Share-based Payment Arrangement, Expense, after Tax 3 month | Share-based Payment Arrangement, Expense, after Tax 6 month | Share-based Payment Arrangement, Expense, after Tax 9 month | Share-based Payment Arrangement, Expense, after Tax 12 month | Share-based Payment Arrangement, Expense, after Tax 12 month as first filed | Share-based Payment Arrangement, Expense, after Tax 104 month |
|---|---|---|---|---|---|---|
| 2016-09-30 | $3.93K 10-Q · filed 2016-11-04 | $105.33K derived: sum of 2 quarters · filed 2016-11-04 | $105.33K derived: sum of 3 quarters · filed 2016-11-04 | $105.33K derived: sum of 4 quarters · filed 2016-11-04 | ||
| 2016-06-30 | $101.40K 10-Q · filed 2016-08-10 | $101.40K derived: sum of 2 quarters · filed 2016-08-10 | $101.40K derived: sum of 3 quarters · filed 2016-08-10 | $101.40K derived: sum of 4 quarters · filed 2016-11-04 | ||
| 2016-03-31 | $0.00 10-Q · filed 2016-05-06 | $0.00 derived: sum of 2 quarters · filed 2016-05-06 | $0.00 derived: sum of 3 quarters · filed 2016-11-04 | $0.00 derived: sum of 4 quarters · filed 2016-11-04 | ||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-28 | $0.00 derived: sum of 2 quarters · filed 2016-11-04 | $0.00 derived: sum of 3 quarters · filed 2016-11-04 | $74.90K 10-K · filed 2016-03-28 | ||
| 2015-09-30 | $0.00 10-Q · filed 2016-11-04 | $0.00 derived: sum of 2 quarters · filed 2016-11-04 | $74.90K 10-Q · filed 2015-11-10 | $321.45K derived: sum of 4 quarters · filed 2016-11-04 | ||
| 2015-06-30 | $0.00 10-Q · filed 2016-08-10 | $74.90K 10-Q · filed 2015-08-07 | $321.45K derived: sum of 3 quarters · filed 2016-08-10 | $397.31K derived: sum of 4 quarters · filed 2016-08-10 | ||
| 2015-03-31 | $74.90K 10-Q · filed 2016-05-06 | $321.45K derived: sum of 2 quarters · filed 2016-05-06 | $397.31K derived: sum of 3 quarters · filed 2016-05-06 | $453.87K derived: sum of 4 quarters · filed 2016-05-06 | ||
| 2014-12-31 | $246.55K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-28 | $322.41K derived: sum of 2 quarters · filed 2016-03-28 | $378.97K derived: sum of 3 quarters · filed 2016-03-28 | $759.60K 10-K · filed 2016-03-28 | $946.17K 10-K · filed 2015-03-27 | |
| 2014-09-30 | $75.86K 10-Q · filed 2015-11-10 | $132.42K derived: sum of 2 quarters · filed 2015-11-10 | $513.04K 10-Q · filed 2015-11-10 | $531.39K derived: sum of 4 quarters · filed 2015-11-10 | ||
| 2014-06-30 | $56.56K 10-Q · filed 2015-08-07 | $437.19K 10-Q · filed 2015-08-07 | $455.53K derived: sum of 3 quarters · filed 2015-08-07 | $470.23K derived: sum of 4 quarters · filed 2015-08-07 | ||
| 2014-03-31 | $380.63K 10-Q · filed 2015-05-13 | $398.97K derived: sum of 2 quarters · filed 2015-05-13 | $413.67K derived: sum of 3 quarters · filed 2015-05-13 | $452.58K derived: sum of 4 quarters · filed 2015-05-13 | $3.20M 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $18.34K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-27 | $33.04K derived: sum of 2 quarters · filed 2015-03-27 | $71.95K derived: sum of 3 quarters · filed 2015-03-27 | $119.25K 10-K · filed 2015-03-27 | ||
| 2013-09-30 | $14.70K 10-Q · filed 2014-11-12 | $53.61K derived: sum of 2 quarters · filed 2014-11-12 | $100.91K 10-Q · filed 2014-11-12 | |||
| 2013-06-30 | $38.91K 10-Q · filed 2014-08-08 | $86.21K 10-Q · filed 2014-08-08 | ||||
| 2013-03-31 | $47.30K 10-Q · filed 2014-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B |